Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
5.43M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
1.68M
-
Shares change
-
-436K
-
Total reported value, excl. options
-
$1.09M
-
Value change
-
-$365K
-
Put/Call ratio
-
0.03
-
Number of buys
-
1
-
Number of sells
-
-19
-
Price
-
$0.65
Significant Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q3 2022
31 filings reported holding APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q3 2022.
Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.68M shares
of 5.43M outstanding shares and own 30.84% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (312K shares), VANGUARD GROUP INC (310K shares), RENAISSANCE TECHNOLOGIES LLC (283K shares), BlackRock Inc. (186K shares), GEODE CAPITAL MANAGEMENT, LLC (150K shares), MILLENNIUM MANAGEMENT LLC (121K shares), BNP PARIBAS ARBITRAGE, SNC (61.8K shares), STATE STREET CORP (40.8K shares), GROUP ONE TRADING, L.P. (31K shares), and NORTHERN TRUST CORP (28.7K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.